Roxithromycin Pellets

(Product under development)
Roxithromycin PelletsRoxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.

Roxithromycin is derived from erythromycin, containing the same 14-membered lactone ring. However, an N-oxime side chain is attached to the lactone ring. It is also currently undergoing clinical trials for the treatment of male-pattern hair loss.

Roxithromycin is available under several brandnames, for example, Xthrocin, Roxl-150, Roxo, Surlid, Rulide, Biaxsig, Roxar, Roximycin, Roxomycin, Rulid, Tirabicin and Coroxin.

Roxithromycin is not available in the United States. Roxithromycin has also been tested to possess antimalarial activity.

Available Form:
Roxithromycin Pellets
Roxithromycin Granules

Umang Pharmatech equipments used for production of Roxithromycin Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.


Roxithromycin Pellets
Systematic (IUPAC) Name
Roxithromycin Pellets
Identifiers
Roxithromycin Pellets
Chemical data
(3R,4S,5S,6R,7R,9R,11S,12R,13S,
14R)-6-[(2S,3R,4S,6R)-4-d-3-hydroxy-6
-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-
5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one
CAS number : 80214-83-1
ATC code : J01
PubChem : CID 6915744
DrugBank : APRD01305
ChemSpider : 5291557
UNII : 21KOF230FA
KEGG : D01710
ChEBI : CHEBI:48935
ChEMBL : CHEMBL1214185
Formula : C41H76N2O15
Mol. mass : 837.047 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL